共 50 条
- [21] Urinary incontinence in Alzheimer's disease is associated with Clinical Dementia Rating-Sum of Boxes and Barthel Activities of Daily LivingASIA-PACIFIC PSYCHIATRY, 2015, 7 (01) : 113 - 120Na, Hae RiPark, Moon HoCho, Sung TaeLee, Byung ChulPark, SuyeolKim, Khae HawnChoi, Jong Bo
- [22] Evaluating the Effect of Coenzyme Q10 Augmentation on Treatment of Bipolar Depression: A Double-Blind Controlled Clinical TrialJOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (05) : 460 - 466Mehrpooya, MaryamYasrebifar, FatemehHaghighi, MohammadMohammadi, YounesJahangard, Leila
- [23] Double-blind trial of aniracetam on cognitive deterioration in 622 cases of benign senescent forgetfulness, vascular dementia, and Alzheimer's diseaseTOWARDS PROLONGATION OF THE HEALTHY LIFE SPAN: PRACTICAL APPROACHES TO INTERVENTION, 1998, 854 : 508 - 509Ma, YXYu, ZYJin, YSYu, SMYe, YZGao, ZXFang, YSHong, ZDing, ZL
- [25] DOES EPIDURAL ADMINISTRATION OF BUTORPHANOL OFFER ANY CLINICAL ADVANTAGE OVER THE INTRAVENOUS ROUTE - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALANESTHESIOLOGY, 1992, 76 (02) : 216 - 220CAMANN, WRLOFERSKI, BLFANCIULLO, GJSTONE, MLDATTA, S
- [26] A randomized, double-blind, placebo-controlled clinical trial to evaluate pregabalin efficacy in the treatment of behavioral and psychological symptoms of dementia in patients with Alzheimer's diseaseFRONTIERS IN NEUROSCIENCE, 2024, 18Maleki, LeylaMohammadian, FatemehPanahishokouh, MahsaMohebbi, Niayesh
- [27] Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer typePHARMACOPSYCHIATRY, 1999, 32 (03) : 99 - 106Möller, HJHampel, HHegerl, USchmitt, WWalter, K
- [28] Impact of Inotersen on Functioning and Activities of Daily Living for Patients with Hereditary TTR Amyloidosis: Results from a Double-Blind Placebo-Controlled TrialBLOOD, 2018, 132Yarlas, AaronMerlini, GiampaoloWhite, Michelle K.Kessler, Asia SikoraLovley, AndrewGuthrie, Spencer D.Pollock, MichaelGertz, Morie A.
- [29] Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical TrialFRONTIERS IN NEUROLOGY, 2018, 9Agahi, AzadehHamidi, Gholam AliDaneshvar, RezaHamdieh, MostafaSoheili, MasoudAlinaghipour, AzamTaba, Seyyed Mohammad EsmaeiliSalami, Mahmoud
- [30] Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: A randomized placebo-controlled double-blind clinical trialNEUROTHERAPEUTICS, 2024, 21 (03)Moussavi, ZahraUehara, MariaRutherford, GrantLithgow, BrianMillikin, ColleenWang, XikuiSaha, ChandanMansouri, BehzadOmelan, CraigFellows, LesleyFitzgerald, Paul B.Koski, Lisa